The function and effectiveness of MSCs in preclinical models of diseases

Abstract

Mesenchymal stem cells (MSCs) have shown immense promise across diverse fields, particularly in treating various diseases. A multitude of preclinical investigations, encompassing both laboratory cellular-level studies and animal trials, have demonstrated the significant effectiveness of MSCs in addressing a broad spectrum of diseases. These studies collectively highlight the enormous potential of therapies utilizing MSCs across a range of medical scenarios. From neurological and cardiovascular disorders to autoimmune and musculoskeletal disorders, including recent challenges like COVID-19, MSCs present therapeutic possibilities due to their versatile capabilities. These discoveries lay a robust foundation for further clinical research and the eventual translation of MSC-based treatments into mainstream clinical practice, offering renewed optimism for patients contending with complex medical conditions.